Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 261,287 | 74,297 | 75,490 | 136,700 | 87,282 |
| Marketable Securities | 178,107 | 174,037 | 122,112 | 31,528 | 76,734 |
| Receivables | 54,518 | 25,839 | 3,213 | 1,487 | 652 |
| Inventories | N/A | 4,954 | 22,145 | 6,699 | N/A |
| TOTAL | $500,205 | $288,307 | $229,128 | $184,440 | $167,567 |
| Non-Current Assets | |||||
| PPE Net | 21,075 | 29,826 | 37,376 | 37,537 | 33,625 |
| Other Non-Current Assets | 97,841 | 11,189 | 12,458 | 7,930 | 7,785 |
| TOTAL | $118,916 | $41,015 | $49,834 | $45,467 | $41,410 |
| Total Assets | $619,121 | $329,322 | $278,962 | $229,907 | $208,977 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,589 | 9,762 | 10,187 | 21,726 | 6,436 |
| Accrued Expenses | 27,546 | 26,186 | 21,850 | 26,835 | 18,132 |
| TOTAL | $76,465 | $60,541 | $41,040 | $54,938 | $65,134 |
| Non-Current Liabilities | |||||
| Long Term Debt | 132,964 | 158,147 | 174,672 | N/A | N/A |
| Deferred Revenues | 12,735 | 12,183 | 7,864 | 6,116 | 40,333 |
| Other Non-Current Liabilities | 306,068 | 0 | 1,653 | 992 | 0 |
| TOTAL | $447,531 | $180,229 | $199,697 | $30,917 | $33,987 |
| Total Liabilities | $523,996 | $240,770 | $240,737 | $85,855 | $99,121 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 143,388 | 141,160 | 121,474 | 107,987 | 106,957 |
| Common Shares | 143 | 141 | 121 | 108 | 101 |
| Retained earnings | -1,110,115 | -967,446 | -777,828 | -505,016 | -432,392 |
| Other shareholders' equity | -86 | -19 | 2 | 5 | 6 |
| TOTAL | $95,125 | $88,552 | $38,225 | $144,052 | $109,856 |
| Total Liabilities And Equity | $619,121 | $329,322 | $278,962 | $229,907 | $208,977 |